PBAXU

Phoenix Biotech Acquisition Corp. Unit
PBAXU

Overview Fund Activity
Delisted

PBAXU was delisted on the 7th of February, 2024.

Back to rankings

21 hedge funds and large institutions have $21.1M invested in Phoenix Biotech Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$241K
2
FTUS
Flow Traders U.S.
New York
$116K
3
CS
Clear Street
New York
$77K
4
CSS
Cubist Systematic Strategies
Connecticut
$257K
5
LCM
Landscape Capital Management
New Jersey
$168K

Top Sellers

1
CL
CSS LLC
Illinois
$0
2
BCM
Basso Capital Management
Connecticut
$0
3
SFM
Spartan Fund Management
Canada
$0
4
FTCM
First Trust Capital Management
Illinois
$0
5
SMA
Sage Mountain Advisors
Georgia
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FTCM
26
First Trust Capital Management
Illinois
– -$453K -45,000 Closed
SMA
27
Sage Mountain Advisors
Georgia
– -$358K -35,610 Closed
Calamos Advisors
28
Calamos Advisors
Illinois
– -$252K -25,000 Closed
RCM
29
Robinson Capital Management
Michigan
– -$10K -956 Closed
1
2